Early life functional advantage coupled with accelerated aging: The case for antagonistic pleiotropy in Huntington's disease
Journal of Huntington's Disease · 2025
DOI: 10.1177/18796397251391069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Huntington's Disease, 2025. Verfasst von Jordan L Schultz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Carver College of Medicine at the University of Iowa, Iowa City, IA, USA. Hauptthemen laut MEDLINE: Huntington Disease, Aging, Genetic Pleiotropy, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Recent findings suggest that neurodevelopment plays a critical role in Huntington's Disease (HD) pathogenesis. This review integrates data from human studies of children and young adults at risk for HD (the Kids-HD study) with the theory of antagonistic pleiotropy (AP), which posits that genes promoting early-life advantages may confer late-life risks. Longitudinal imaging of gene-expanded (GE) children and adolescents shows that mHTT is associated with larger cortical volumes, enhanced surface morphology, and superior cognitive performance—decades before clinical onset. However, this early benefit is paired with accelerated striatal decline, suggesting that mHTT drives an early “ability” that transitions into a “liability.” Vertex-wise analyses reveal cortical enlargement in regions with dense glutamatergic projections to the striatum, implicating excitotoxicity as a mechanism linking development to degeneration. This pleiotropic pattern parallels evolutionary models, where genes like HTT may have an evolutionary trade-off where genes supporting growth and reproduction are favored over those that serve long-term somatic maintenance, leaving cells with diminished repair capacity and resulting in an accelerated aging process. Altogether, these findings support a novel framework in which mHTT accelerates both brain maturation and neurodegeneration, offering new insights into HD biology and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Carver College of Medicine at the University of Iowa, Iowa City, IA, USA.
- Department of Neurology, Carver College of Medicine at the University of Iowa, Iowa City, IA, USA.
- Department of Pharmacy Practice and Science, The University of Iowa College of Pharmacy, Iowa City, IA, USA.
- Stead Family Department of Pediatrics at the University of Iowa, Iowa City, IA, USA.
Zitieren
APA
Schultz, J. L., & Nopoulos, P. C. (2025). Early life functional advantage coupled with accelerated aging: The case for antagonistic pleiotropy in Huntington's disease. Journal of Huntington's Disease. https://doi.org/10.1177/18796397251391069
Vancouver
Schultz JL, Nopoulos PC. Early life functional advantage coupled with accelerated aging: The case for antagonistic pleiotropy in Huntington's disease. Journal of Huntington's Disease. 2025. doi:10.1177/18796397251391069
BibTeX
@article{Schultz2025,
author = {Schultz, Jordan L and Nopoulos, Peg C},
title = {Early life functional advantage coupled with accelerated aging: The case for antagonistic pleiotropy in Huntington's disease},
journal = {Journal of Huntington's Disease},
year = {2025},
doi = {10.1177/18796397251391069}
}
EUVIMED